Nivien Therapeutics' Convertible Note Round

Nivien Therapeutics raised a round of funding on September 12, 2017.

General Biotechnologies identifies and develops undervalued discoveries in the life sciences. The company's flagship program - Nivien Therapeutics - is an oncology platform. Nivien is a new platform t…

Articles about Nivien Therapeutics' Convertible Note Round: